EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

New hemiaminal ether dihydropyrimidinones as CK1/CK2 inhibitors targeting α-synuclein in Parkinson's disease

Hamza Wakeel, Shanza Munir, Humaira Yasmeen Gondal iD, Zain Maqsood Cheema, Aleena Muskan, Imran Malik, Muhammad Nisar, Hina Siddiqui iD, Sadaf Khaliq Sultan

RSC Advances · 2026

DOI: 10.1039/d6ra06901k ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Hamza Wakeel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Education Lahore Pakistan. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to develop new dihdropyrimidones based inhibitors to slow Parkinson's disease progression by targeting casein kinase CK1, CK2, and α-synuclein receptors.

Autor:innen und Institutionen

  • Department of Chemistry, University of Education Lahore Pakistan.
  • Institute of Chemistry, University of Sargodha Sargodha Pakistan humaira.yasmeen@uos.edu.pk.
  • Department of Pharmacology, Faculty of Pharmacy, Riphah International University Islamabad Pakistan.
  • H.E.J Research Institute of Chemistry, ICCBS, University of Karachi Karachi Pakistan.
  • WHO Sub-office, DHDC, Aziz Bhatti Shaheed Teaching Hospital Gujrat Pakistan.

ORCID-Profile: Humaira Yasmeen Gondal, Hina Siddiqui

Zitieren

APA

Wakeel, H., Munir, S., Gondal, H. Y., Cheema, Z. M., Muskan, A., Malik, I., Nisar, M., Siddiqui, H., & Sultan, S. K. (2026). New hemiaminal ether dihydropyrimidinones as CK1/CK2 inhibitors targeting α-synuclein in Parkinson's disease. RSC Advances. https://doi.org/10.1039/d6ra06901k

Vancouver

Wakeel H, Munir S, Gondal HY, Cheema ZM, Muskan A, Malik I, et al. New hemiaminal ether dihydropyrimidinones as CK1/CK2 inhibitors targeting α-synuclein in Parkinson's disease. RSC Advances. 2026. doi:10.1039/d6ra06901k

BibTeX
@article{Wakeel2026,
  author = {Wakeel, Hamza and Munir, Shanza and Gondal, Humaira Yasmeen and Cheema, Zain Maqsood and Muskan, Aleena and Malik, Imran and Nisar, Muhammad and Siddiqui, Hina and Sultan, Sadaf Khaliq},
  title = {New hemiaminal ether dihydropyrimidinones as CK1/CK2 inhibitors targeting α-synuclein in Parkinson's disease},
  journal = {RSC Advances},
  year = {2026},
  doi = {10.1039/d6ra06901k}
}
Kostenlos starten →